BNTX logo

BNTX
BioNTech SE - ADR

19,092
Mkt Cap
$22.99B
Volume
958,566.00
52W High
$124.00
52W Low
$79.52
PE Ratio
-15.49
BNTX Fundamentals
Price
$90.93
Prev Close
$90.36
Open
$89.97
50D MA
$94.53
Beta
0.85
Avg. Volume
856,275.85
EPS (Annual)
-$5.30
P/B
1.07
Rev/Employee
$414,872.02
$5,894.82
Loading...
Loading...
News
all
press releases
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
PFE targets high single-digit revenue CAGR from 2029 as new launches, acquisitions and pipeline growth may offset LOE headwinds.
News Placeholder
More News
News Placeholder
Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00
Wells Fargo & Company lowered their price target on shares of BioNTech from $150.00 to $140.00 and set an "overweight" rating for the company in a report on Wednesday...
News Placeholder
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts
Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eighteen research firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold re...
News Placeholder
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth
Pfizer beats Q1 estimates as new launches and acquired drugs lift sales, offsetting COVID declines, while the drugmaker reaffirms its 2026 outlook.
News Placeholder
BioNTech Q1 Earnings Call Highlights
BioNTech (NASDAQ:BNTX) executives used the company's first-quarter 2026 earnings call to highlight a strategy centered on combination oncology therapies, provide updates on late-stage clinical...
News Placeholder
BioNTech (NASDAQ:BNTX) Announces Earnings Results
BioNTech (NASDAQ:BNTX - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($2.26) earnings per share for the quarter, topping analysts' consensus estimates of...
News Placeholder
Mitsubishi UFJ Trust & Banking Corp Sells 92,271 Shares of BioNTech SE Sponsored ADR $BNTX
Mitsubishi UFJ Trust & Banking Corp decreased its position in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 59.8% during the fourth quarter, according to the company in its most recent...
News Placeholder
Pictet Asset Management Holding SA Buys 26,119 Shares of BioNTech SE Sponsored ADR $BNTX
Pictet Asset Management Holding SA lifted its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 41.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 88,838 shares of the company's stock after acquirin...
News Placeholder
BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?
BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next...
News Placeholder
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings
Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support long-term upside?
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available